Dr Reddys Laboratories Share Price Today - Live Blog for March 25, 2025

The stock of Dr Reddys Laboratories Ltd is making significant strides, boasting a 0.43% increase and currently trading at ₹1,180.55 per share. This upward trajectory is turning heads in the market.

Dr Reddys Laboratories Ltd's shares saw an increase of 0.43%, reaching the current market price of ₹1,180.55. This development underscores the stock's growing popularity.

Dr Reddys Laboratories Ltd's share price has dropped by -0.06%, a development that warrants careful analysis. Presently trading at ₹1,174.25, investors are assessing whether this presents an opportunity or a risk.

The share price of Dr Reddys Laboratories Ltd experienced a -0.47% slump and is currently trading at ₹1,174.15. While the stock maintains a PE ratio of 18.8000, the industry PE is 34.5704, raising questions about valuation.

The share price of Dr Reddys Laboratories Ltd soared by an impressive 0.17%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,183.25 per share.

Climbing steadily, Dr Reddys Laboratories Ltd shares have ascended by 0.17%, reaching the current market price of ₹1,183.25. This ascent signifies increased investor sentiment. The stock has an ROE of 17.3623% and debt to equity ratio of 0.1579.

Dr Reddys Laboratories Ltd share price surged by 0.10%. With its current market price standing at ₹1,183.00 per share, this stock is garnering increased attention from the investment community.

Dr Reddys Laboratories Ltd's stock price surged by 0.06%, reaching the current market value of ₹1,181.00 per share. This surge is a testament to the stock's recent performance.

Dr Reddys Laboratories Ltd's share price has experienced a notable 0.06% upswing, and it's currently trading at ₹1,181.00 per share. Investors are closely watching this development.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 0.06% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,181.00 per share. The stock has an ROE of 17.3623% and debt to equity ratio of 0.1579.

Climbing steadily, Dr Reddys Laboratories Ltd shares have ascended by 0.26%, reaching the current market price of ₹1,180.35. This ascent signifies increased investor sentiment. The stock has an ROE of 17.3623% and debt to equity ratio of 0.1579.

After a significant 0.26% gain, Dr Reddys Laboratories Ltd's shares are now valued at ₹1,180.35 in the current market. This upward movement is attracting attention from both retail and institutional investors.

With a remarkable 0.14% increase in value, the share price of Dr Reddys Laboratories Ltd currently stands at ₹1,177.35. Notably, this stock has a Price-to-Earnings (PE) ratio of 18.8000, while the industry's PE ratio is 34.5704.

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.01%, signalling a challenging period. Currently trading at ₹1,174.60, this stock has caught the eye of bargain hunters, who may be considering their entry points.

Dr Reddys Laboratories Ltd's share price has fallen by -0.03%, a situation worth noting. At present, the stock is trading at ₹1,174.00. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 18.8000, while the industry PE ratio is 34.5704.

The stock of Dr Reddys Laboratories Ltd is facing a -0.31% decline and is currently trading at ₹1,174.35 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

The share price of Dr Reddys Laboratories Ltd recently experienced a positive upturn, resulting in a 0.12% increase. Presently, it is actively trading at ₹1,178.00.

Dr Reddys Laboratories Ltd's shares experienced a 0.14% uptick, and they are currently valued at ₹1,176.10, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.1579 and an ROE of 17.3623%.

Dr Reddys Laboratories Ltd's shares experienced a 0.32% uptick, and they are currently valued at ₹1,174.50, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.1579 and an ROE of 17.3623%.

Dr Reddys Laboratories Ltd's stock price surged by 0.06%, reaching the current market value of ₹1,170.75 per share. This surge is a testament to the stock's recent performance.

Dr Reddys Laboratories Ltd's share price stayed unchanged, currently trading at ₹1,170.75. The stock has a PE ratio of 18.8000, an ROE of 17.3623%, and a debt to equity ratio of 0.1579.

Dr Reddys Laboratories Ltd experienced a -0.14% dip in its share price and is currently trading at ₹1,172.15. The stock has a PE ratio of 18.8000, an ROE of 17.3623% and a debt to equity ratio of 0.1579.

The stock of Dr Reddys Laboratories Ltd suffered a -0.40% drop, and it's now trading at ₹1,170.75 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

The share price of Dr Reddys Laboratories Ltd recently experienced a positive upturn, resulting in a 0.36% increase. Presently, it is actively trading at ₹1,175.20.

Dr Reddys Laboratories Ltd displayed price stability, with no changes, and is trading at ₹1,170.35. This sustained performance invites investors to assess whether the stock aligns with their long-term investment goals.

The share price of Dr Reddys Laboratories Ltd experienced a -0.74% slump and is currently trading at ₹1,171.75. While the stock maintains a PE ratio of 18.8000, the industry PE is 34.5704, raising questions about valuation.

The share price of Dr Reddys Laboratories Ltd plunged by -0.25%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,180.55, but investors are assessing whether this is a temporary dip or a long-term trend.

The stock of Dr Reddys Laboratories Ltd is on the rise, registering an impressive 0.40% increase and currently trading at ₹1,183.10 per share. Investors are taking notice of this upward momentum.

The stock of Dr Reddys Laboratories Ltd suffered a -0.20% decline, and it currently trades at ₹1,177.45 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

The stock of Dr Reddys Laboratories Ltd suffered a -4.79% decline, and it currently trades at ₹1,180.60 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.